Podocyte apoptosis has been proposed as a mechanism of podocyte loss and glomerulosclerosis in a transforming growth factor -β1 transgenic mouse model [34], a knockout for CD2AP [35], a puromycin-induced lesion model [15], and mouse and human glomerular epithelial cell cultures [36]. The gene discussed is CD2AP; the disease is glomerulosclerosis.